THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 25 filers reported holding THERAVANCE INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $2,867 | -99.7% | 2,870,000 | +170.8% | 0.02% | +140.0% |
Q3 2022 | $1,041,000 | -68.5% | 1,060,000 | -65.6% | 0.01% | -73.7% |
Q3 2021 | $3,309,000 | +5.7% | 3,080,000 | 0.0% | 0.04% | +8.6% |
Q2 2021 | $3,130,000 | – | 3,080,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellesley Asset Management | 41,771 | $44,921,000 | 2.37% |
LINDEN ADVISORS LP | 45,495,000 | $48,853,000 | 1.16% |
BASSO CAPITAL MANAGEMENT, L.P. | 4,759,000 | $5,092,000 | 0.94% |
SSI INVESTMENT MANAGEMENT LLC | 6,850,000 | $7,332,000 | 0.60% |
TEALWOOD ASSET MANAGEMENT INC | 1,390,000 | $1,492,000 | 0.59% |
Castle Creek Arbitrage, LLC | 6,070,000 | $6,516,000 | 0.48% |
OAKTREE CAPITAL MANAGEMENT LP | 21,717,000 | $23,355,000 | 0.37% |
AQR Arbitrage LLC | 27,018,000 | $29,055,000 | 0.34% |
CSS LLC/IL | 5,000,000 | $5,360,000 | 0.27% |
CQS Cayman LP | 4,150,000 | $4,469,000 | 0.21% |